Skip to main content

Trending:

How the FDA approved a $300,000-a-year drug its own experts didn’t believe worked

By The Wall Street Journal  
   May 19, 2017

After trial data for a new medicine proved inconclusive, Sarepta Therapeutics joined with the parents of sick boys to persuade officials it helped.

Full story

Tagged Under:

accountability
FDA

Get the latest on healthcare leadership in your inbox.

Subscribe